Why Ritalin Rules.(prescription drug for Attention Deficit Disorder): An article from: Policy Review

This digital document is an article from Policy Review, published by Hoover Institution Press on April 1, 1999. The length of the article is 7356 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: The extensive use of the drug Ritalin to treat children for Attention Deficit Disorder (ADD) may be a sign of disease in society that is more severe than any reputed disease in the children. The society has changed since the mid-1980s to view what may be normal childhood activity as lack of behavioral compliance. Books, support groups, and statements from psychiatric organizations have legitimized ADD and the use of Ritalin.

Citation Details
Title: Why Ritalin Rules.(prescription drug for Attention Deficit Disorder)
Author: Mary Eberstadt
Publication:Policy Review (Refereed)
Date: April 1, 1999
Publisher: Hoover Institution Press
Page: NA

Distributed by Thomson Gale